Bilateral subthalamic nucleus stimulation for generalized dystonia after bilateral pallidotomy

Imagem de Miniatura
Arquivos
art_FONOFF_Bilateral_subthalamic_nucleus_stimulation_for_generalized_dystonia_after_2012.PDF (266.42 KB)
Citações na Scopus
39
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
CAMPOS, Wuilker Knoner
ALHO, Eduardo Joaquim Lopes
Citação
MOVEMENT DISORDERS, v.27, n.12, p.1559-1563, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Thalamotomies and pallidotomies were commonly performed before the deep brain stimulation (DBS) era. Although ablative procedures can lead to significant dystonia improvement, longer periods of analysis reveal disease progression and functional deterioration. Today, the same patients seek additional treatment possibilities. Methods: Four patients with generalized dystonia who previously had undergone bilateral pallidotomy came to our service seeking additional treatment because of dystonic symptom progression. Bilateral subthalamic nucleus DBS (B-STN-DBS) was the treatment of choice. The patients were evaluated with the BurkeFahnMarsden Dystonia Rating Scale (BFMDRS) and the Unified Dystonia Rating Scale (UDRS) before and 2 years after surgery. Results: All patients showed significant functional improvement, averaging 65.3% in BFMDRS (P = .014) and 69.2% in UDRS (P = .025). Conclusions: These results suggest that B-STN-DBS may be an interesting treatment option for generalized dystonia, even for patients who have already undergone bilateral pallidotomy. (c) 2012 Movement Disorder Society
Palavras-chave
dystonia, thalamotomy, pallidotomy, subthalamic nucleus
URI
https://observatorio.fm.usp.br/handle/OPI/495
Referências
  1. ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X
  2. Alho EJL, 2011, NEUROIMAGING CLIN CO, P145
  3. Benabid AL, 2001, J NEUROL S3, pIII37, DOI 10.1007/PL00007825
  4. Blahak C, 2008, J NEUROL, V255, P178, DOI 10.1007/s00415-008-0614-3
  5. Bressman SB, 2000, CLIN NEUROPHARMACOL, V23, P239, DOI 10.1097/00002826-200009000-00002
  6. Chou KL, 2005, MOVEMENT DISORD, V20, P377, DOI 10.1002/mds.20341
  7. Coubes P, 2000, LANCET, V355, P2220, DOI 10.1016/S0140-6736(00)02410-7
  8. DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V
  9. Fahn S, 1998, Adv Neurol, V78, P1
  10. Giron LT, 1996, DRUG SAFETY, V14, P365
  11. Jankovic M., 2002, Medical and Pediatric Oncology, V38, P124, DOI 10.1002/mpo.1286
  12. Kim JP, 2011, STEREOT FUNCT NEUROS, V89, P205, DOI 10.1159/000325660
  13. Kleiner-Fisman G, 2007, J NEUROSURG, V107, P29, DOI 10.3171/JNS-07/07/0029
  14. Krack P, 2001, EUR J NEUROL, V8, P389, DOI 10.1046/j.1468-1331.2001.00231.x
  15. Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618
  16. Lagrange E, 2002, NEUROLOGY, V59, P1976
  17. Lozano AM, 1997, MOVEMENT DISORD, V12, P865, DOI 10.1002/mds.870120606
  18. McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024
  19. Mogilner AY, 2002, J NEUROSURG, V96, P660, DOI 10.3171/jns.2002.96.4.0660
  20. Novak KE, 2008, STEREOT FUNCT NEUROS, V86, P80, DOI 10.1159/000112428
  21. Pastor-Gomez J, 2003, REV NEUROLOGIA, V37, P529
  22. Spearing MK, 1997, PSYCHIAT RES, V73, P159, DOI 10.1016/S0165-1781(97)00123-6
  23. Sun B, 2007, ACTA NEUROCHIR SUPPL, V97, P207
  24. Tronnier VM, 2000, J NEUROSURG, V92, P453, DOI 10.3171/jns.2000.92.3.0453
  25. Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187
  26. Vitek JL, 2002, MOVEMENT DISORD, V17, pS49, DOI 10.1002/mds.10142

Coleções
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/26